# ClearCam

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clearcam

- Industry: Medical Devices & Equipment
- Headquarters: Austin, US
- Website: www.clearcam-med.com
- Latest round: Seed (Dec 24, 2018)
- Investors on record: 1

## About

ClearCam Inc. is a US-based healthcare company focused on enhancing surgical performance through innovative laparoscopic lens cleaning solutions, primarily via its flagship product, the ClearCam System.Founded in 2018 and headquartered in Austin, US, ClearCam Inc. specializes in medical devices that improve surgical visibility. The company was established by Christopher Idelson, Christopher Rylander, Douglas Stoakley, and John Uecker, with John Uecker currently serving as the CEO. ClearCam has completed four investment deals, with the most recent being a Seed round on February 9, 2023, raising USD 3.77 mn from The University of Texas at Austin, bringing the total amount raised to USD 3.77 mn and its current valuation to USD 20.608 mn.ClearCam specializes in innovative solutions for laparoscopic lens cleaning, primarily through its flagship product, the ClearCam System. This system is designed to enhance visual clarity during surgical procedures by utilizing a sophisticated wiper mechanism that ensures optimal contact with the laparoscopic lens. The product's unique 5mm design accommodates standard 0° and 30° laparoscopes, making it compatible with a broad range of surgical tools used in minimally invasive procedures. ClearCam aims to address critical issues in the operating room, such as poor visualization and contamination, which are associated with nearly 20% of surgical injuries and can significantly prolong operating times. The company's clientele includes hospitals and surgical centers across various geographical markets, including North America and Europe, where it serves surgeons and healthcare professionals seeking to improve surgical outcomes and efficiency.ClearCam generates revenue through direct sales of its ClearCam System to healthcare facilities, primarily targeting hospitals and surgical centers that require high-performance laparoscopic tools. The transaction structure is based on a direct-to-business model, focusing on B2B sales to ensure reliable access to their products for medical professionals. The pricing strategy for the ClearCam System aligns with the value it provides in enhancing surgical visibility and efficiency, although specific pricing details are not disclosed. The company also focuses on building partnerships with medical institutions to facilitate bulk purchases and training on using their products effectively, reinforcing the value proposition of maintaining clear visual fields during surgery. These sales and partnership agreements contribute to ClearCam's positioning within the medical device market, aiming to establish long-term relationships with clients to foster ongoing support and product adoption.In February 2023, ClearCam Inc. raised USD 3.77 mn in Seed funding to support product adaptation, expand its operations, and invest in the advancement of its technology. The company aims to enhance its product offerings and is planning to introduce new solutions tailored for the surgical market. Additionally, ClearCam is exploring opportunities to expand into new geographic markets, including Asia and South America, by the end of 2024. The recent funding will assist in these initiatives and bolster their market presence.

## Funding rounds

- Seed, Dec 24, 2018 — Texas Halo Fund

## Investors

- Texas Halo Fund (https://capitalatlas.ai/funds/texas-halo-fund) — Seed